Cg Oncology Inc (CGON)

EBITDA Growth

-89.50%

Quarterly · Period ending:

CGON logo

CGON EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-89.50%
CGON Quarterly EBITDA YoY % (-69.48% → -89.50%)
High-resolution chart · PNG

CGON ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Cg Oncology Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-89.4984%
-72.4207%
-27.2407%
-112.8728%
-118.4176%
-103.379%
-97.356%
-73.2891%
-62.7617%
-95.4057%
-69.4751%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.